Mankind Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Mankind Pharma has a total shareholder equity of ₹86.3B and total debt of ₹1.8B, which brings its debt-to-equity ratio to 2.1%. Its total assets and total liabilities are ₹111.0B and ₹24.6B respectively. Mankind Pharma's EBIT is ₹20.0B making its interest coverage ratio 161.7. It has cash and short-term investments of ₹23.3B.
Key information
2.1%
Debt to equity ratio
₹1.79b
Debt
Interest coverage ratio | 161.7x |
Cash | ₹23.26b |
Equity | ₹86.34b |
Total liabilities | ₹24.65b |
Total assets | ₹110.98b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: MANKIND's short term assets (₹56.6B) exceed its short term liabilities (₹21.3B).
Long Term Liabilities: MANKIND's short term assets (₹56.6B) exceed its long term liabilities (₹3.4B).
Debt to Equity History and Analysis
Debt Level: MANKIND has more cash than its total debt.
Reducing Debt: Insufficient data to determine if MANKIND's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: MANKIND's debt is well covered by operating cash flow (1150.5%).
Interest Coverage: MANKIND's interest payments on its debt are well covered by EBIT (161.7x coverage).